01
Oct
Atmo Biosciences has signed a licensing deal with RMIT University securing the exclusive worldwide rights to commercialize a ground-breaking ingestible gas-sensing capsule.
Atmo Biosciences has signed a licensing deal with RMIT University securing the exclusive worldwide rights to commercialize a ground-breaking ingestible gas-sensing capsule.
Findings from the first human trials of a breakthrough gas-sensing swallowable capsule could revolutionize the way that gut disorders and diseases are prevented and diagnosed.